Early treatment with rifaximin during epileptogenesis reverses gut alterations and reduces seizure duration in a mouse model of acquired epilepsy

Valentina Kebede,Teresa Ravizza,Silvia Balosso,Rossella Di Sapia,Luca Canali,Sara Soldi,Serena Galletti,Christina Papazlatani,Panagiotis A. Karas,Sotirios Vasileiadis,Annalisa Sforzini,Laura Pasetto,Valentina Bonetto,Annamaria Vezzani,Loredana Vesci
DOI: https://doi.org/10.1016/j.bbi.2024.04.007
IF: 19.227
2024-04-14
Brain Behavior and Immunity
Abstract:The gut microbiota is altered in epilepsy and is emerging as a potential target for new therapies. We studied the effects of rifaximin, a gastrointestinal tract-specific antibiotic, on seizures and neuropathology and on alterations in the gut and its microbiota in a mouse model of temporal lobe epilepsy (TLE). Epilepsy was induced by intra-amygdala kainate injection causing status epilepticus (SE) in C57Bl6 adult male mice. Sham mice were injected with vehicle. Two cohorts of SE mice were fed a...
immunology,neurosciences,psychiatry
What problem does this paper attempt to address?